|
Reanalyzing MERIT design using Julia + recent numerical algorithms
|
|
5
|
349
|
August 11, 2026
|
|
Clinicians increased awareness of RCT structure
|
|
1
|
182
|
August 8, 2026
|
|
French target trial using obs data of HCQ vs not in SARS-CoV-2 infection
|
|
10
|
3504
|
August 5, 2026
|
|
Randomized non-comparative trials: an oxymoron?
|
|
89
|
5126
|
July 10, 2026
|
|
Statistical Process Control and Experimental Design
|
|
10
|
562
|
July 8, 2026
|
|
Cause-Agnostic RCT (CAR)
|
|
10
|
620
|
July 5, 2026
|
|
The Ethics of Underpowered Trials
|
|
11
|
310
|
July 2, 2026
|
|
Statin-related side effects: the recent Lancet publication is biased toward false-negatives
|
|
34
|
1046
|
June 21, 2026
|
|
Relaxing Assumptions and Targeted Estimands with MOST
|
|
12
|
285
|
May 27, 2026
|
|
A Longitudinal Renal Health Outcome for Clinical Trials in Acute Kidney Injury?
|
|
15
|
266
|
May 22, 2026
|
|
The growing interest in integrating causal inference and Design Theory
|
|
13
|
599
|
May 16, 2026
|
|
Best model reduction approach for Fine-Gray prediction model
|
|
5
|
147
|
March 27, 2026
|
|
Scoping review + SOCI: to assess DHIS2 applicability for NCD
|
|
2
|
96
|
March 26, 2026
|
|
FDA Draft Guidance: Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products
|
|
10
|
1169
|
March 2, 2026
|
|
One-sided significance threshold of less than 0.1 in Phase 2 clinical trial
|
|
7
|
210
|
February 25, 2026
|
|
Bootstrapped variable selection in the presence of competing risk
|
|
7
|
190
|
January 12, 2026
|
|
Should causal modeling be a required part of a NIH grant applications?
|
|
1
|
133
|
December 17, 2025
|
|
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders – Results from the 2 NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model
|
|
2
|
129
|
December 11, 2025
|
|
MICE Imputation Models
|
|
10
|
499
|
December 6, 2025
|
|
NEJM Trial - proportional hazard assumption
|
|
12
|
499
|
December 1, 2025
|
|
The Design Theory /Causal Inference Divide Explained by the Position of U
|
|
2
|
187
|
November 28, 2025
|
|
Rarity Roulette: A simulator for estimating hypothetical outcomes spreads for mass screenings
|
|
2
|
133
|
November 20, 2025
|
|
Individual response
|
|
266
|
49815
|
November 17, 2025
|
|
When and why (not) to worry about the PO assumption
|
|
4
|
778
|
October 9, 2025
|
|
Comparing multiple groups to a reference group
|
|
7
|
265
|
October 6, 2025
|
|
Bayesian Clinical Trials: Interview with Frank Harrell
|
|
0
|
260
|
September 18, 2025
|
|
Estimating the probability of neonatal sepsis with plug-in incidence
|
|
6
|
190
|
September 11, 2025
|
|
Fine-Gray vs Cause-Specific Cox Regression
|
|
0
|
206
|
September 11, 2025
|
|
Sample Size Calculation for a 2x2 Factorial RCT
|
|
6
|
518
|
September 3, 2025
|
|
Table 2 Fallacy?: Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
|
|
32
|
4354
|
August 12, 2025
|